FDA allows more flexible storage conditions for Pfizer/BioNTech COVID-19 vaccine

FDA allows more flexible storage conditions for Pfizer/BioNTech COVID-19 vaccine

Submitted by admin on March 1, 2021 - 10:56am
Source: 
Biopharma Reporter
News Tags: 
Pfizer
BioNTech
vaccines
COVID-19
logistics
Headline: 
FDA allows more flexible storage conditions for Pfizer/BioNTech COVID-19 vaccine
snippet: 

The Pfizer/BionTech COVID-19 vaccine – which requires ultra-cold storage – will now be allowed to be transported and stored at standard freezer temperatures for up to two weeks in the US.

Do Not Allow Advertisers to Use My Personal information